Therapy Areas
DRUG CLASSES
View Sessions
UPCOMING
Join us forour roundtable in||latest advances in||your questions on||new therapies for||practice changes in||your patient cases in
SMALL CELL Lung Cancer
Jacob Sands
USA
Solange Peters
Switzerland
Giannis Mountzios
Greece
Agenda & Discussion Topics
THE EMERGING ROLE OF DLL3 T-CELL ENGAGERS IN SCLCGiannis Mountzios |
EXPANDING OUR OPTIONS WITH IO COMBINATION THERAPIES IN LS- AND ES-SCLCJacob Sands |
Open Discussion, Viewer Questions & Patient CasesSolange Peters |
Join our host, Solange Peters, for an insightful roundtable on evolving treatment strategies in small cell lung cancer (SCLC). This interdisciplinary roundtable brings together renowned experts Giannis Mountzios and Jacob Sands to explore the emerging role of DLL3 T-cell engagers, recent trial updates, and approaches to managing immune-related adverse events (irAEs) in SCLC. The discussion will cover the expanding role of immuno-oncology (IO) combination therapies, including the latest data and their place in the current treatment paradigm. Don’t miss this opportunity to deepen your understanding, engage with experts through interactive case discussions, and discover the future of combination strategies in SCLC treatment.
ADD THIS TO YOUR CALENDAR
Google Calendar (Online)
Outlook Calendar (Offline)
-
Outlook On Microsoft Office 365 (Online)
-
Outlook On The Web (Online)
Apple Offline Calendar / iCal
When: 5:00 PM - 6:30 PM (CEST)
Register here
Do You Already Have An Account?
No need to sign up again: as a verified user, you will have access to all our sessions. Simply login to participate in this event.
First Time On Lung Summit?